Single-center clinical study of HPV vaccination in children with cancer rehabilitation

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300077687

Enrollment

Unknown

Registered

2023-11-16

Start date

2023-12-01

Completion date

Unknown

Last updated

2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

children with tumor

Interventions

Intervent group:HPV vaccine

Eligibility

Sex/Gender

Female

Age

9 Years to 24 Years

Inclusion criteria

Inclusion criteria: Subjects: adolescents and young female (9-24 years old) tumor survivors who have completed full treatment and are in continuous remission for at least 1 year.

Exclusion criteria

Exclusion criteria: Pregnant women, lactating women, immune system diseases, and those allergic to vaccine components were excluded.

Design outcomes

Secondary

Measure	Time frame
Local reactions and systemic reaction;HPV ANTIBODY;HPV vaccination rate and vaccination intention ;	—

Countries

China

Contacts

Public ContactCai Jiaoyang

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine

caijiaoyang@scmc.com.cn+86 136 2162 7180

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026